Efficacy of FK463, a new lipopeptide antifungal agent, in mouse models of pulmonary aspergillosis

Antimicrobial Agents and Chemotherapy

Volumn 44, Issue 3, 2000, Pages 619-621

  Matsumoto, Satoru ^a   Wakai, Yoshimi ^a   Nakai, Toru ^a   Hatano, Kazuo ^a   Ushitani, Tomoe ^a   Ikeda, Fumiaki ^a   Tawara, Shuichi ^a   Goto, Toshio ^a   Matsumoto, Fumio ^b   Kuwahara, Shogo ^c  

^a ASTELLAS PHARMA INC   (Japan)

^b Kanagawa Pref Nursing Hygienic S   (Japan)

^c TOHO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE; LIPOPEPTIDE; MICAFUNGIN;

ADOLESCENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLUS FUMIGATUS; CONTINUOUS INFUSION; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFICACY; LUNG ASPERGILLOSIS; MALE; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

AMPHOTERICIN B; ANIMALS; ANTIBIOTICS, ANTIFUNGAL; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; LIPOPROTEINS; LUNG DISEASES, FUNGAL; MICE; MICE, INBRED ICR; MICROBIAL SENSITIVITY TESTS; PEPTIDES, CYCLIC; TREATMENT OUTCOME;

EID: 0034003477     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.44.3.619-621.2000     Document Type: Article

References (10)

1. Abruzzo, G. K., A. M. Flattery, C. J. Gill, L. Kong, J. G. Smith, V. B. Pikounis, J. M. Balkovec, A. F. Bouffard, J. F. Dropinski, H. Rosen, H. Kropp, and K. Bartizal. 1997. Evaluation of the echinocandin antifungal MK-0991 (L-743,872): efficacies in mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis. Antimicrob. Agents Chemother. 41: 2333-2338.
2. Beck-Sague, C. M., W. R. Jarvis, and the National Nosocomial Infections Surveillance System. 1993. Secular trends in the epidemiology of nosocomial fungal infections in the United States. 1980-1990. J. Infect. Dis. 167:1247-1251.
3. DeGregorio, M. W., W. M. F. Lee, C. A. Linker, R. A. Jacobs, and C. A. Ries. 1982. Fungal infections in patients with acute leukemia. Am. J. Med. 73: 543-548.
4. Denning, D. W., and D. A. Stevens. 1990. Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases. Rev. Infect. Dis. 12:1147-1201.
5. Denning, D. W., L. Hall, M. Jackson, and S. Hollis. 1995. Efficacy of D0870 compared with those of itraconazole and amphotericin B in two murine models of invasive aspergillosis. Antimicrob. Agents Chemother. 39:1809-1814.
6. Graybill, J. R., R. Bocanegra, L. K. Najvar, D. Loebenberg, and M. F. Luther. 1998. Granulocyte colony-stimulating factor and azole antifungal therapy in murine aspergillosis: role of immune suppression, Antimicrob. Agents Chemother. 42:2467-2473.
7. Petraitis, V., R. Petraitiene, A. H. Groll, A. Bell, D. P. Callender, T. Sein, R. L. Schufele, C. L. McMillian, J. Bacher, and T. J. Walsh. 1998. Antifungal efficacy, safety, and single-dose pharmacokinetics of LY303366, a novel echinocandin B, in experimental pulmonary aspergillosis in persistently neutropenic rabbits. Antimicrob. Agents Chemother. 42:2898-2905.
8. Rogers, A. L., and M. J. Kennedy. 1991. Opportunistic hyaline hyphomycetes, p. 659-673. In A. Balows, W. J. Hausler, Jr., K. L. Herrmann, H. D. Isenberg, and H. J. Shadomy (ed.), Manual of clinical microbiology, 5th ed. American Society for Microbiology, Washington, D.C.
9. Warren, N. G., and H. J. Shadomy. 1991. Yeasts of medical importance, p. 617-629. In A. Balows, W. J. Hausler, Jr., K. L. Herrmann, H. D. Isenberg, and H. J. Shadomy (ed.), Manual of clinical microbiology, 5th ed. American Society for Microbiology, Washington, D.C.
10. Young, L. S. 1989. Aspergillus infection in the neutropenic host. Hosp. Pract. 30(May):37-43.